Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioalma is a Spanish bioinformatics company specializing in advanced text-mining and data-integration technologies for the life sciences sector. Founded in 2001, the company developed the AlmaKnowledgeServer (AKS), a platform that utilizes natural language processing to extract and analyze biological relationships from scientific literature. This technology enables pharmaceutical and biotech researchers to efficiently navigate vast amounts of unstructured data to identify potential drug targets and biomarkers. In 2009, Bioalma was acquired by Progenika Biopharma, a move intended to bolster Progenika's capabilities in personalized medicine and genomic diagnostics. The company's expertise has been instrumental in bridging academic bioinformatics research with commercial drug discovery applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioalma.